A transdermal patch delivering the PTHrP1-34 analog, abaloparatide (BA058), dose-dependently increases spine and hip bmd compared to placebo

John Yates; Peter Alexandersen; Annesofie Krogsaa; Bettina Nedergaard; Marcie Clarkin; Gary Hattersley; Kris Hansen; Morten Karsdal; Claus Christiansen

doi:10.1530/boneabs.3.PP351

OP1

Prev Next

Section Contents Cite

Bone Abstracts (2014) 3 OP1 | DOI: 10.1530/boneabs.3.PP351

Clinical

A transdermal patch delivering the PTHrP_1--34 analog, abaloparatide (BA058), dose-dependently increases spine and hip bmd compared to placebo

John Yates, Peter Alexandersen, Annesofie Krogsaa, Bettina Nedergaard, Marcie Clarkin, Gary Hattersley, Kris Hansen, Morten Karsdal & Claus Christiansen

97 views

see PP351.

Volume 3

European Calcified Tissue Society Congress 2014

Prague, Czech Republic
17 May 2014 - 20 May 2014

European Calcified Tissue Society

Browse other volumes

Summary Abstract Book Programme Volume Editors eposters Abstracts

Article tools

| Disclaimer

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.

Authors

Yates John

Google Scholar
PubMed

Alexandersen Peter

Google Scholar
PubMed

Krogsaa Annesofie

Google Scholar
PubMed

Nedergaard Bettina

Google Scholar
PubMed

Clarkin Marcie

Google Scholar
PubMed

Hattersley Gary

Google Scholar
PubMed

Hansen Kris

Google Scholar
PubMed

Karsdal Morten

Google Scholar
PubMed

Christiansen Claus

Google Scholar
PubMed

Bone Abstracts

OP1

A transdermal patch delivering the PTHrP1--34 analog, abaloparatide (BA058), dose-dependently increases spine and hip bmd compared to placebo